A study has found that patients with cancer who receive chemotherapy -- and some targeted therapies, such as CDK4/6 inhibitors and therapies targeted at B cells -- may mount an inadequate immune response to COVID-19 vaccination.
from Top Health News -- ScienceDaily https://ift.tt/3rtNifK
via IFTTT
No comments:
Post a Comment